Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001628280-24-046462

EVP and General Counsel sold 4,397 shares at $10.11 ($44,454)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
de Verneuil Vanina EVP and General Counsel 2024-11-06 Sale 10b5-1 −4,397 $10.11 $44,454 56,973 D
Open-market sales · 4,397 sh · avg $10.11 · $44,454
Loading xslF345X05/wk-form4_1731025248.xml…